Efficiency droop in light-emitting diodes: Challenges and countermeasures: Efficiency droop in light-emitting diodes: Challenges and countermeasures
Explore the source record for details and available documents.
SEARCH · Engineering Papers
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Urban air temperature rises induced by the urban heat island (UHIE) effect or by global warming (GW) can be beneficial in winter but detrimental in summer. The SCIENCE-Outdoor model was used to simulate changes to sensible heat release and CO 2 emissions from buildings yielded by four UHIE countermeasures and five GW countermeasures. This model can evaluate the thermal condition of building envelope surfaces, both inside and outside. The results showed that water-consuming UHIE countermeasures such as evaporative space cooling and roof water showering provided positive effects (decreasing sensible heat release and CO 2 emissions related to space conditioning) in summer. Additionally, they had no negative (unwanted cooling) effects in winter since they can be turned off in the heating season. Roof greening can provide the greatest space- conditioning CO 2 emissions reductions among four UHIE countermeasures, and it reduces the amount of heat release slightly in the heating season. Since the effect on reducing carbon dioxide (CO 2 ) emissions by UHIE countermeasures is not very significant, it is desirable to introduce GW countermeasures in order to reduce CO 2 emissions. The significance of this study is that it constructed the new simulation model SCIENCE-Outdoor and applied it to show the influence of countermeasures upon both heat release and CO 2 emissions.
While there are numerous performance metrics that have been developed for the evaluation of distracted driving prevention programs, there is little information on how to select them depending on the requirements and/or objectives of the study. Here, this paper describes a systematic literature review that was conducted on the metrics for evaluating distracted driving countermeasures in order to bridge this research gap. A summary of the evaluation metrics used for the existing distracted driving countermeasures was provided. Guidance for choosing an evaluation measure was provided by analyzing the metrics from the perspectives of functionality, spatial-temporal dimension, and equity. Three examples of distracted driving countermeasure evaluation processes were thoroughly reviewed in order to offer insight into metric selection and measurement. This paper contributes to the body of knowledge by discussing the implications for policy on how to enhance the thoroughness and accuracy of the evaluation of distracted driving countermeasures. Analysis from multiple angles, the development of data collection tools and direct behavior indicators, taking into account temporal dimensions, and equity considerations, are proposed.
The convergence of Information Technologies and Operational Technology systems in industrial networks presents many challenges related to availability, integrity, and confidentiality. In this paper, we evaluate the various cybersecurity risks in industrial control systems and how they may affect these areas of concern, with a particular focus on energy-sector Operational Technology systems. There are multiple threats and countermeasures that Operational Technology and Information Technology systems share. Since Information Technology cybersecurity is a relatively mature field, this paper emphasizes on threats with particular applicability to Operational Technology and their respective countermeasures. We identify regulations, standards, frameworks and typical system architectures associated with this domain. We review relevant challenges, threats, and countermeasures, as well as critical differences in priorities between Information and Operational Technology cybersecurity efforts and implications. These results are then examined against the recommended National Institute of Standards and Technology framework for gap analysis to provide a complete approach to energy sector cybersecurity. We provide analysis of countermeasure implementation to align with the continuous functions recommended for a sound cybersecurity framework.
The Ebola virus disease outbreak that occurred in Western Africa from 2013–2016, and subsequent smaller but increasingly frequent outbreaks of Ebola virus disease in recent years, spurred an unprecedented effort to develop and deploy effective vaccines, therapeutics, and diagnostics. This effort led to the U.S. regulatory approval of a diagnostic test, two vaccines, and two therapeutics for Ebola virus disease indications. Moreover, the establishment of fieldable diagnostic tests improved the speed with which patients can be diagnosed and public health resources mobilized. The United States government has played and continues to play a key role in funding and coordinating these medical countermeasure efforts. Here, we describe the coordinated U.S. government response to develop medical countermeasures for Ebola virus disease and we identify lessons learned that may improve future efforts to develop and deploy effective countermeasures against other filoviruses, such as Sudan virus and Marburg virus.
Cybersecurity is essential to maintaining operations, and is now a de facto cost of business. Despite this, there is little consensus on how to systematically make decisions about cyber countermeasures investments. Identifying gaps and determining the expected return on investment (ROI) of adding a new cybersecurity countermeasure is frequently a hand-waving exercise at best. Worse, cybersecurity nomenclature is murky and frequently over-loaded, which further complicates issues by inhibiting clear communication. This paper presents a series of foundational models and nomenclature for discussing cybersecurity countermeasures, and then introduces the Cyber Defense (CyDef) model, which provides a systematic and intuitive way for decision-makers to effectively communicate with operations and device experts.
The recent alleged use of A-series chemical warfare agents (CWAs) highlights the urgent need to better understand their inhibition of cholinesterase enzymes and the reported shortcomings of traditional oxime countermeasures. Here, using high-throughput (HT) mass spectrometry (MS) technologies, we characterized the largely unknown inhibition kinetics of A-series CWAs on human acetylcholinesterase (hAChE) and its reactivation by oximes, achieving label-free quantitation at rates of up to 7,000 reactions per hour. Our findings indicate i) A-series agents exhibit inhibitory potencies similar to traditional CWAs like sarin and VX, and ii) bipyridinium-based oximes can reactivate A-series-adducted hAChE in vitro, challenging prior reports on oxime efficacy. These results underscore the need for continued exploration of countermeasure candidates against A-series CWAs and demonstrate the potential of HT-MS for rapidly and safely characterizing emerging toxic chemicals.
Abstract Organophosphate (OP) toxicants remain an active threat to public health and to warfighters in the military. Current countermeasures require near immediate administration following OP exposure and are reported to have controversial efficacies. Acetylcholinesterase (AChE) fused to the human immunoglobulin 1 (IgG1) Fc domain (AChE‐Fc) is a potential bioscavenger for OP toxicants, but a reproducible AChE‐Fc biomanufacturing strategy remains elusive. This report is the first to establish a comprehensive laboratory‐scale bioprocessing strategy that can reproducibly produce AChE‐Fc and AChE(W86A)‐Fc which is a mutated AChE protein with reduced enzymatic activity. Characterization studies revealed that AChE‐Fc and AChE(W86A)‐Fc are N ‐glycosylated dimeric fusion glycoproteins but only AChE‐Fc had the capability to bind to paraoxon (a model OP). This AChE‐Fc fusion glycoprotein bioprocessing strategy can be leveraged during industrial biomanufacturing development, while the research‐grade AChE‐Fc proteins can be used to determine the potential clinical relevance of the countermeasure against OP toxicants.
The only medication available currently to prevent and treat opioid overdose (naloxone) was approved by the US Food and Drug Administration (FDA) nearly 50 years ago. Due to its pharmacokinetic and pharmacodynamic properties, naloxone has limited utility under some conditions and would not be effective to counteract mass casualties involving large-scale deployment of weaponized synthetic opioids. To address shortcomings of current medical countermeasures for opioid toxicity, a trans-agency scientific meeting was convened by the US National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) on August 6 and 7, 2019, to explore emerging alternative approaches for treating opioid overdose in the event of weaponization of synthetic opioids. The meeting was initiated by the Chemical Countermeasures Research Program (CCRP), was organized by NIAID, and was a collaboration with the National Institute on Drug Abuse/NIH (NIDA/NIH), the FDA, the Defense Threat Reduction Agency (DTRA), and the Biomedical Advanced Research and Development Authority (BARDA). This paper provides an overview of several presentations at that meeting that discussed emerging new approaches for treating opioid overdose, including the following: (1) intranasal nalmefene, a competitive, reversible opioid receptor antagonist with a longer duration of action than naloxone; (2) methocinnamox, a novel opioid receptor antagonist; (3) covalent naloxone nanoparticles; (4) serotonin (5-HT)1A receptor agonists; (5) fentanyl-binding cyclodextrin scaffolds; (6) detoxifying biomimetic “nanosponge” decoy receptors; and (7) antibody-based strategies. These approaches could also be applied to treat opioid use disorder.
Chlorine is a commonly used, reactive compound to which humans can be exposed via accidental or intentional release resulting in acute lung injury. Formulations of rolipram (a phosphodiesterase inhibitor), triptolide (a natural plant product with anti-inflammatory properties), and budesonide (a corticosteroid), either neat or in conjunction with poly(lactic:glycolic acid) (PLGA), were developed for treatment of chlorine-induced acute lung injury by intramuscular injection. Formulations were produced by spray-drying, which generated generally spherical microparticles that were suitable for intramuscular injection. Multiple parameters were varied to produce formulations with a wide range of in vitro release kinetics. Testing of selected formulations in chlorine-exposed mice demonstrated efficacy against key aspects of acute lung injury. The results show the feasibility of developing microencapsulated formulations that could be used to treat chlorine-induced acute lung injury by intramuscular injection, which represents a preferred route of administration in a mass casualty situation. - Highlights: • Chlorine causes lung injury when inhaled and is considered a chemical threat agent. • Countermeasures for treatment of chlorine-induced acute lung injury are needed. • Formulations containing rolipram, triptolide, or budesonide were produced. • Formulations with a wide range of release properties were developed. • Countermeasure formulations inhibited chlorine-induced lung injury in mice.
Yersinia pestis , the causative agent of plague and a biological threat agent, presents an urgent need for novel medical countermeasures due to documented cases of naturally acquired antibiotic resistance and potential person-to-person spread during a pneumonic infection. Immunotherapy has been proposed as a way to circumvent current and future antibiotic resistance. Here, we describe the development and characterization of two affinity matured human antibodies (αF1Ig AM2 and αF1Ig AM8) that promote survival of mice after exposure to aerosolized Y . pestis . We share details of the error prone PCR and yeast display technology-based affinity maturation process that we used. The resultant matured antibodies have nanomolar affinity for Y . pestis F1 antigen, are produced in high yield, and are resilient to 37°C stress for up to 6 months. Importantly, in vitro assays using a murine macrophage cell line demonstrated that αF1Ig AM2 and αF1Ig AM8 are opsonic. Even more importantly, in vivo studies using pneumonic plague mouse models showed that 100% of the mice receiving 500 μg of IgGs αF1Ig AM2 and αF1Ig AM8 survived lethal challenge with aerosolized Y . pestis CO92. Combined, these results provide evidence of the quality and robustness of αF1Ig AM2 and αF1Ig AM8 and support their development as potential medical countermeasures against plague.
This paper introduces a frequency-domain false data injection attack called Frequency Spectrum Attack (FSA) and explores its effects on load forecasting and the energy management system (EMS) in a microgrid. The FSA analyzes time-series signals in the frequency domain to identify patterns in their frequency spectrum. It learns the distribution of dominant frequencies in a dataset of healthy signals. Subsequently, it manipulates the amplitudes of dominant frequencies within this healthy distribution, ensuring a stealthy attack against statistical analysis of the signal spectrum. We evaluated the performance of FSA on LSTM, a state-of-the-art network for load forecasting. The results show that FSA can triple the Mean Absolute Error (MAE) of predictions compared to the normal case and increase it by 70% compared to noise injection attacks. Furthermore, FSA indirectly enhances battery utilization in the EMS by 45%. We then proposed a detection method that combines statistical analysis and machine-learning-based classification techniques with features. The model effectively distinguishes FSA from healthy and noisy signals, achieving an accuracy of 98.7% and an F1-score of 98.1% on a load dataset, covering healthy, FSA, and noisy load data. Finally, a countermeasure was introduced based on the statistical analysis of the frequency spectrum of healthy signals to mitigate the impact of FSA. This countermeasure successfully reduces the MAE of the attacked model from 0.135 to 0.053, validating its effectiveness in mitigating FSA.
Organophosphoate (OP) chemicals are known to inhibit the enzyme acetylcholinesterase (AChE). Studying OP poisoning is difficult because common small animal research models have serum carboxylesterase, which contributes to animals’ resistance to OP poisoning. Historically, guinea pigs have been used for this research; however, a novel genetically modified mouse strain (KIKO) was developed with nonfunctional serum carboxylase (Es1 KO) and an altered acetylcholinesterase (AChE) gene, which expresses the amino acid sequence of the human form of the same protein (AChE KI). KIKO mice were injected with 1xLD50 of an OP nerve agent or vehicle control with or without atropine. After one to three minutes, animals were injected with 35 mg/kg of the currently fielded Reactivator countermeasure for OP poisoning. Postmortem brains were imaged on a Bruker RapifleX ToF/ToF instrument. Data confirmed the presence of increased acetylcholine in OP-exposed animals, regardless of treatment or atropine status. More interestingly, we detected a small amount of Reactivator within the brain of both exposed and unexposed animals; it is currently debated if reactivators can cross the blood–brain barrier. Further, we were able to simultaneously image acetylcholine, the primary affected neurotransmitter, as well as determine the location of both Reactivator and acetylcholine in the brain. This study, which utilized sensitive MALDI-MSI methods, characterized KIKO mice as a functional model for OP countermeasure development.
A countermeasure system for use by a target to protect against an incoming sensor-guided threat. The system includes a laser system for producing a broadband beam and means for directing the broadband beam from the target to the threat. The countermeasure system comprises the steps of producing a broadband beam and directing the broad band beam from the target to blind or confuse the incoming sensor-guided threat.
A concept has been developed for a next-generation integrated countermeasure architecture to detect improvised explosive devices hidden on people or left behind in unstructured crowds. The work is part of the Standoff Technology Integration and Demonstration Program of the U.S. Department of Homeland Security’s Science and Technology Directorate. The architecture is based on results from an initial design tested in crowd conditions and a broad survey of existing and emerging technologies. The architecture uses a layered-defense approach that automates screening operations and prioritizes threats and mobilizes resources accordingly. A system tracks people as they move, integrating sensors to optimize threat identification accuracy and screening resources. A threat-based decision module prioritizes screening targets based on user-defined rules. Operators manage system-wide risk and mobilize field teams for interdiction. DHS is working with industry on technology development and testing to achieve the required level of system integration and economics in crowd conditions.
In preparation for operations at the Radiological/Nuclear Countermeasures Test and Evaluation Complex (Rad/NucCTEC), the Department of Homeland Security Domestic Nuclear Detection Office (DHS/DNDO) requested that personnel from the Remote Sensing Laboratory (RSL) conduct a survey of the present radiological conditions at the facility. The measurements consist of the exposure rate from a high-pressure ion chamber (HPIC), high-resolution spectra from a high-purity germanium (HPGe) system in an in situ configuration, and low-resolution spectra from a sodium iodide (NaI) detector in a radiation detection backpack. Measurements with these systems were collected at discrete locations within the facility. Measurements were also collected by carrying the VECTOR backpack throughout the complex to generate a map of the entire area. The area was also to be surveyed with the Kiwi (an array of eight-2-inch x 4-inch x 16-inch NaI detectors) from the Aerial Measuring Systems; however, conflicts with test preparation activities at the site prevented this from being accomplished.
China is a maritime power. However, as its economy develops rapidly, China lacks freshwater resources. The water resources per capita are low in China and are less than a quarter of the global mean value. The development and utilization of desalination, a new unconventional water resource in coastal areas, has gradually attracted the attention of the central and local governments. This paper introduces three aspects of the comprehensive utilization of seawater in China, including the desalination of seawater, the direct use of seawater, and the use of seawater as a chemical resource. Based on the recent status (2017) of comprehensive seawater utilization in China, the prospects for optimizing the utilization of seawater resources are presented. Furthermore, the restrictive factors and potential countermeasures for the increased use of seawater desalination are investigated. Several recommendations are presented, specifically, improving the laws, using regulations and standards related to desalination, strengthening the policies that support enterprises that use desalination, gradually improving the localization rate of key technologies and equipment, and devoting additional attention to the problems associated with brine processing. Seawater is expected to become an important supplemental source of water in coastal areas of China, and the resources needed for its use will be developed as a strategic and influential industry.
Subetadex-α-methyl (SBX-Me), a modified, polyanionic cyclodextrin scaffold, has been evaluated for its utilization as a medical countermeasure (MCM) to neutralize the effects of fentanyl and related opioids. Initial in vitro toxicity assays demonstrate that SBX-Me has a nontoxic profile, comparable to the FDA-approved cyclodextrin-based drug Sugammadex. Pharmacokinetic analysis showed rapid clearance of SBX-Me with an elimination half-life of ~7.4 h and little accumulation in major organs. SBX-Me was also evaluated for its ability to counteract the effects of fentanyl, carfentanil, and remifentanil in rats. Recovery times in rats exposed to sublethal fentanyl doses were found to be shorter when treated with SBX-Me after opioid exposure. The recovery times were reduced from ~35 to ~17 min for fentanyl, ~172 to ~59 min for carfentanil, and ~18 to ~12 min for remifentanil. SBX-Me increased the elimination half-life for fentanyl and remifentanil from 5.37 to 6.42 h and 8.24 to 9.74 h, respectively. These data support SBX-Me as a solid platform from which further research can be launched for the development of a MCM against the effects of fentanyl and its analogs. Furthermore, the data suggests that SBX-Me and other analogs are attractive candidates as broad spectrum opioids targeting MCMs.